• Flanders Investment & Trade
  • Team Vesalius

Graduating from the University of Ghent, Rudi Mariën is the current chairman of the biotech company Innogenetics, which he co-founded with Erik Tambuyzer and Hugo Van Heuverswyn in 1985.

Rudi Mariën


Technologiepark 6
9052 Ghent

In addition, he is also the founder, shareholder and managing director of several clinical reference laboratories such as the Barc Group, Cerba European Lab, Gengest and Biovest. Mariën holds additional board positions in multiple listed and private biotech companies.

Team Vesalius visionairies

Flanders’ life sciences industry: the perfect combo of biotech, medtech, pharma and healthcare

Defining Flanders’ life sciences industry as diverse is an understatement. From young start-ups to established local firms and multinationals: the entire value chain – from research and discovery to development and commercialization – is represented in Belgium’s northern region. Thanks to fertile cross-pollination between biotech, medtech, pharmaceuticals and healthcare, Flanders offers a unique life sciences ecosystem that is underpinned by a robust financing landscape and a supportive government. Will your company claim its place in this dynamic hub?